Abstract:Objective To analyze the correlation between protein expression of X -ray repair cross complementing group 1 (XRCC1)and excision repair cross complementing 1 (ERCC1)with efficacy of concurrent radiochemotherapy(CRT)and the prognosis of patients with esophageal aquamous cell carcinoma(ESCC).Methods Immunohistochemical SP method was used to measure the protein expression of XRCC1 and ERCC in 98 ESCC tissue samples before CRT.The Kaplan -Meier method was used for survival analysis,and the log rank test was used for analyzing the survival difference between negative and positive sam-ples.The Cox model was used for multivariate prognostic analysis.Results XRCC1 and ERCC1 protein were mainly expressed in the nucleus in ESCC.There was no correlation between them (r =-0.024,P =0.811 ).The positive expression rate of XRCC1 protein in ESCC tissues and normal esophageal tissues were 57.1%(56 /98)and 13.3%(4 /30)respectively (χ2 =17.702,P =0.000).The positive expression rate of ERCC1 protein in ESCC tissues and normal esophageal tissues were 36.7%(36 /98)and 10%(3 /30)respectively(χ2 =7.749,P =0.006).The level of ERCC1 was not correlated with clinical pathologic characteristics (P >0.05).The positive expression rate of ERCC1 protein in negative lymphnode group was 44.9% (31 /69), higher than 17.2% (5 /29)in positive lymphnode group,and the difference was statistically significant (χ2 =8.183,P =0.004).The patients with positive XRCC1 expression and negative XRCC1 expression had similar short -term responses(χ2 =0.894,P =0.344)as well as similar survival rates(χ2 =0.266,P =0.606).The RR of ERCC1 negative expression group was 90.3%(56 /62),and the RR of ERCC1 positive expression group was 80.5%(29 /36),but there was no statistically significant difference (χ2 =1.888,P =0.169).The median overall survival periods of ERCC1 negative expression group was 39 months (95% CI:29.313 ~48.687 months),higher than 25 months (95% CI:18.559 ~31.441 months)in positive expression group, the difference was statistically significant (χ2 =10.174,P =0.001).In multivariate analysis,the expression of ERCC1 was closely correlated with overall survival and was the independent prognostic factor (P =0.010,95% CI:1.180 ~3.450).Conclusion ERCC1 expression was associated with the efficacy of CRT,and the patients with ERCC1 positive expression had poor prognosis.

HOXC10 Upregulation Confers Resistance to Chemoradiotherapy in ESCC Tumor Cells and Predicts Poor Prognosis

Increased HOXC6 Expression Predicts Chemotherapy Sensitivity in Patients with Esophageal Squamous Cell Carcinoma.

Downregulation of HOXA13 sensitizes human esophageal squamous cell carcinoma to chemotherapy.

The survival predictive significance of HOXC6 and HOXC8 in esophageal squamous cell carcinoma.

Hoxa13 Promotes Cancer Cell Growth and Predicts Poor Survival of Patients with Esophageal Squamous Cell Carcinoma

HOXC10 Promotes Migration and Invasion Via the WNT-EMT Signaling Pathway in Oral Squamous Cell Carcinoma.

Upregulation of HOXA10 Protein Expression Predicts Poor Prognosis for Colorectal Cancer.

HOXC6 Promotes Migration, Invasion and Proliferation of Esophageal Squamous Cell Carcinoma Cells Via Modulating Expression of Genes Involved in Malignant Phenotypes

Prognostic and predictive role of COX-2, XRCC1 and RASSF1 expression in patients with esophageal squamous cell carcinoma receiving radiotherapy.

RASSF10 Exhibits Tumor‑suppressing Potential Involving Tumor Proliferation, Metastasis and Epithelial‑mesenchymal Transition in Esophageal Squamous Cell Carcinoma.

HOXC10 Up-Regulation Contributes to Human Thyroid Cancer and Indicates Poor Survival Outcome

Deregulated Hoxb7 Expression Predicts Poor Prognosis Of Patients With Esophageal Squamous Cell Carcinoma And Regulates Cancer Cell Proliferation In Vitro And In Vivo

Data from Characterization of Tumor-Suppressive Function of <i>sox6</i> in Human Esophageal Squamous Cell Carcinoma

Exploring the prognosis value, immune correlation, and drug responsiveness prediction of homeobox C6 (HOXC6) in lung adenocarcinoma

HOXC13 Promotes Proliferation of Esophageal Squamous Cell Carcinoma Via Repressing Transcription of CASP3

Up-regulation of HOXA13 in Esophageal Squamous Cell Carcinoma of Stage II a and Its Effect on the Prognosis

High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy

Xrcc3 is A Promising Target to Improve the Radiotherapy Effect of Esophageal Squamous Cell Carcinoma

Targeting HOX/PBX Dimer Formation As a Potential Therapeutic Option in Esophageal Squamous Cell Carcinoma.

Analysis of correlation between protein expression of XRCC1 and ERCC1 with efficacy of concurrent radiochemotherapy and the prognosis of patients with esophageal aquamous cell carcinoma

Upregulation of the Long Non-Coding Rna Hotair Promotes Esophageal Squamous Cell Carcinoma Metastasis and Poor Prognosis